Molecular mechanisms underlying mifepristone's agonistic action on ovarian cancer progression.
Ponikwicka-Tyszko D, Chrusciel M, Stelmaszewska J, Bernaczyk P, Chrusciel P, Sztachelska M, Scheinin M, Bidzinski M, Szamatowicz J, Huhtaniemi IT, Wolczynski S, Rahman NA.
Ponikwicka-Tyszko D, et al. Among authors: bernaczyk p.
EBioMedicine. 2019 Sep;47:170-183. doi: 10.1016/j.ebiom.2019.08.035. Epub 2019 Aug 26.
EBioMedicine. 2019.
PMID: 31466918
Free PMC article.